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Chapter 7: Understanding Immunesenescence 
 
Whittaker, A.C., Upton, J., Arora Duggal, N., Deb, C., Randhawa, C., Oyebode, J., & Lord, 
J.M. 
University of Birmingham 
 
Chapter Abstract 
This chapter discusses the impact of hip fracture in older age and in particular factors affecting 
recovery of physical function and wellbeing.  It focuses particularly on a study of the impact of 
depression following hip fracture in older adults, and the influence of this depression on a range 
of outcomes including immune function, stress hormones, illness perceptions, physical function, 
and length of stay in health service and rehabilitation facilities.  It shows that depression is 
common following hip fracture among older people, and is the biggest predictor of a slower 
recovery and poorer function in terms of immunity, wellbeing, and physical ability. A pilot study 
associated with this research showed that illness perceptions following hip fracture did not differ 
between UK and Punjabi older adults, but that Punjabi speakers in India had greater levels of 
distress.  Implications for health service policy and practice resulting from this research are 
discussed, including potential intervention strategies to improve outcomes after hip fracture. 
 




With the ageing of the population hip fractures are a growing issue in the UK (Dennison et al., 
2006). At least half of older adults who have suffered a hip fracture never regain their previous 
function (Stevens and Olson, 2000), with mortality at one year recorded as high as 33% (Roche 
et al., 2005). The factors influencing recovery from hip fracture are poorly understood. These 
include depression; a common co-morbidity in these patients (Nightingale et al., 2001).   
 
The prevalence rate for depression in people who have had a hip fracture across eight US and UK 
studies ranged from 9 - 47% (Holmes and House, 2000). Importantly, depression in people who 
have suffered a hip fracture has been associated with increased risk of infections and poor 
survival (Nightingale et al., 2001), impaired recovery and a reduced ability to regain pre-fracture 
levels of physical functioning (Mossey et al., 1990).   
 
It is well documented that ageing is accompanied by poor functioning of the body’s immune 
system (Panda et al., 2009, Dorshkind et al., 2009). This is called immunesenescence or immune 
ageing and it contributes to the increased risk of infection in old age (Gavazzi and Krause, 2002). 
Particular aspects of immune ageing can be observed in specific important immune system cells.  
For example, neutrophils are key cells in the immune system which are responsible for providing 
protection against bacteria such as those that cause hospital acquired infections and pneumonia. 
Ageing is accompanied by a decline in neutrophil ability to ingest such bacteria (Butcher et al., 
2001), and their ability to kill the bacteria once ingested (Tortorella et al., 2000). Similar 
reductions in efficacy have been shown in other immune cells, such as monocytes, with 
advancing age (Shaw et al., 2011).  
 
An additional important component of the immune system are natural killer (NK) cells, which 
are cells capable of destroying cancer cells and cells infected with viruses (Farag et al., 2003). 
Older adults have an age-related decrease in NK cell function (Hazeldine et al., 2012), which 
may explain why older adults are more susceptible to cancer and virus infections such as 
influenza. Further, ageing is also accompanied by changes in immune cells that are very focused 
and kill specific infections because they have encountered them before, this is termed immune 
memory, or because the older adult has had a vaccination to protect them. These cells, called 
lymphocytes, do not function as well in older adults and this reduces the ability to benefit from 
vaccines in old age. In addition, some of these cells have a specific role in dampening down 
immune responses to prevent autoimmune disorders, these are called regulatory cells (Blair et 
al., 2010). Interestingly, a recent study in our group has reported an age-related decrease in the 
numbers and function of this type of cell which might contribute towards an increased risk of 
autoimmune diseases such as rheumatoid arthritis with age (Duggal et al., 2013b).  
  
Interestingly, there is accumulating evidence suggesting that the effects of psychological stress 
and ageing are additive, with chronic stress worsening the effects of ageing on immunity in older 
adults (Kiecolt-Glaser and Glaser, 1999).  For example, older adults who had suffered stressful 
life events, such as bereavement and marital dissatisfaction, have lower levels of antibody 
production in response to the annual ‘flu vaccination than those who had not experienced these 
stressors (Phillips et al., 2006). In addition, neutrophils are susceptible to the effects of stress, 
with their ability to kill bacteria reduced in older people who have suffered the trauma of a hip 
fracture (Butcher et al., 2005) or bereavement (Khanfer et al., 2011).  
 
One of the ways in which stress affects bodily systems, including the immune system, is via the 
production of stress hormones.  Stress is sensed in the brain by the hypothalamus which signals 
the adrenal gland to produce  stress hormones which circulate in the blood and reach immune 
cells and influence their function (Tsigos and Chrousos, 2002). Cortisol is the main stress 
hormone and is a potent immune system suppressor and can also contribute to the development 
of depression (Fischer et al., 2017). Dehydroepiandrosterone sulphate (DHEAS), is another 
steroid hormone produced by the adrenal gland, and has the opposite actions to cortisol being 
anti-depressive (Hough et al., 2017) and immune-enhancing, including the ability to increase the 
bacterial killing mechanisms of neutrophils (Hazeldine et al., 2010, Radford et al., 2010). 
Although cortisol levels generally may not increase with ageing, they are higher in relation to 
DHEAS which decreases with age in men and women (adrenopause), thus ageing is accompanied 
by an elevated cortisol:DHEAS ratio; this may be a key factor contributing towards age-
associated immune dysfunction (Buford and Willoughby, 2008). As stress increases cortisol 
production, this age-related dysfunction is made worse by stress. Our group reported a raised 
cortisol:DHEAS ratio in older hip fracture patients versus young comparable trauma patients, and 
these higher cortisol levels were also accompanied by reduced neutrophil bacterial killing ability 
and increased incidence of bacterial infections like pneumonia (Butcher et al., 2005). 
 
Cortisol levels are often higher in individuals with depression (Deuschle et al., 1997, Lesch et al., 
1988). Higher cortisol levels in older adults have also been associated with frailty, including poor 
standing and walking performance (Peeters et al., 2007). Low levels of DHEAS have also been 
related to poorer physical function (Berkman et al., 1993). Importantly, the cortisol:DHEAS ratio 
is higher in older hip fracture patients than in healthy older adults (Dubin et al., 1999) and 
younger comparable fracture patients (Butcher et al., 2005). This hormone imbalance may thus 
be a major determinant of frailty in older people following hip fracture, as well as their 
susceptibility to infections, particularly in those with concomitant depression. 
 
A pilot study, as part of this larger project, focused on patients’ perceptions of their illness. There 
is evidence to support the connection between illness perceptions and outcomes in a range of 
conditions including chronic fatigue syndrome (Moss-Morris et al., 1996), Addison’s disease 
(Heijmans and De Ridder, 1998) and multiple sclerosis (Jopson and Moss-Morris, 2003). Illness 
perceptions have been found to be related to wellbeing and mood (Murphy et al., 1999), and to 
participation in rehabilitation programmes (Cooper et al., 1999). Further, there is evidence that 
minority cultural groups hold illness perceptions that differ in various respects from the majority 
in the UK (Kim et al., 2012). For research into minority ethnic groups to produce useful findings, 
studies needs to acknowledge variations in religion and culture by working with defined groups. 




2. Aims and Methods 
 
The “Synergistic effects of physical and psychological stress upon immunosenescence” NDA 
study sought to test whether psychological distress, specifically depressive symptoms emerging 
after a hip fracture, would act additively on top of the physical stress of hip fracture to amplify 
the effect of ageing upon immunity (immunesenescence) and physical frailty. It also examined 
the role of the cortisol:DHEAS ratio and cytokines (immune messengers) as potential 
mechanisms that might explain any of the effects on immunity and frailty.  
 
An integrated pilot study within this overall project aimed to explore the implications of attitudes 
to hip fracture of a significant minority ethnic patient group in the UK, and the consequent 
implications for tailoring approaches to rehabilitation. Therefore in this pilot study the intention 
was to recruit only hip fracture patients from the Punjab region of India (excluding Punjabis from 
Pakistan; a different religious group). 
 
Participants with hip fracture were 101 White British older adults of whom 81 were female.  A 
parallel pilot study of Punjabi-speaking older adults was recruited elsewhere for comparison, as 
discussed below.  The participants had an average age of 83.9 years and had been admitted to 
hospital as in-patients with a fractured neck of femur (hip fracture). Participating hospitals were 
all located in the West Midlands, UK.  Participants were all aged 60+ years and did not have any 
existing medical conditions or medications that could affect the immune system, dementia, 
taking antidepressants or having a previous diagnosis of depression before the age of 50 years. In 
this way we aimed to recruit individuals who had likely developed depression post-fracture, 
rather than those who already had a history of depression. Fifty healthy older adults were also 
recruited from the community as a control group via the Birmingham 1000 Elders cohort of 
healthy older adults involved in research at the University of Birmingham. These controls also 
had to meet the criteria above but not have a hip fracture. We also involved a sub-sample of these 
healthy controls to advise us on the usability of the questionnaire packs and tests that were 
administered during the study. 
 
For the integrated pilot study, we attempted to recruit an additional 30 Punjabi hip fracture 
patients concurrently with Caucasian patients from five hospitals in the West Midlands. Only one 
Indian Punjabi patient was recruited, who later withdrew.  Our Steering Group Committee 
including an age- and ethnicity-relevant advisory member had considered barriers to participation 
in advance, and translated validated questionnaires as well as a Punjabi-speaking technician to 
assist with recruitment were employed, however, this did not make a difference to the poor 
recruitment of this sub-sample. 
 
The main research study compared these three groups of older adults: hip fracture patients 
with or without depressive symptoms and healthy older adults at 6-weeks post-fracture. This is 
the first time that previously non-depressed patients have been assessed for emerging 
depression post-hip fracture. All hip fracture patients were recruited while in hospital, then 
completed questionnaires, structured interviews and provided a blood sample six weeks and 
six months after hip fracture.  Control participants completed a depression and anxiety 
symptoms scale and basic demographic information when attending the university for blood 
sampling around the same time as the patients’ 6 week sample. Blood samples were taken 
between 08.00 and 11.00 to minimise any effect of daily variations in steroid levels. None of 
the participants had an acute infection at the time of blood sampling. Interviews were 
performed either in hospital or the participants’ home.  
 
The assays for neutrophil and monocyte function, namely phagocytosis (bacteria ingesting 
ability) and superoxide production (bacteria killing ability) were performed on blood the same 
day as blood sampling. We also looked at numbers of regulatory immune cells. Serum from 
the blood samples from hip fracture patients and healthy control subjects were analysed for 
stress hormones, namely cortisol and DHEAS.  
 
Standard socio-demographics (age, sex, occupation), health behaviour information, and all other 
illnesses present, and medications (prescription and over-the-counter), were recorded by the 
interviewer. The psychological status of the participant was assessed by means of validated 
psychological questionnaires. Depression was evaluated using the Geriatric Depression Scale 
(GDS) (Yesavage et al., 1982).  Depression was defined as a GDS score greater than or equal to 
6 (Sheikh et al., 1986). The Hospital Anxiety and Depression Scale (HADS) was also used to 
confirm the presence of depression and anxiety (Zigmond and Snaith, 1983). The Oxford Hip 
Score (Dawson et al., 1996) (OHS) is a 12-item questionnaire validated to assess activities of 
daily living (ADL) and ability in patients undergoing hip replacement surgery. Physical frailty 
was assessed in part by the OHS but, in addition, upper body strength was measured as handgrip 
strength using a hydraulic hand dynamometer, lower body strength using the Timed Up and Go 
(TUG) test (Podsiadlo and Richardson, 1991) which is getting up and walking speed over three 
metres and back, and the Berg Balance Scale (BBS) (Berg et al., 1992). The BBS comprises 
activities to assess balance standing and during the performance of tasks. Body mass index 
(BMI) was computed as kg/m2 from measured height and weight. Health behaviours, including 
smoking, alcohol intake, diet, exercise, and sleep duration, were recorded using a simple 
questionnaire adapted from the Whitehall study (Marmot et al., 1991). 
 
For the pilot study, given the difficulties of recruitment of Punjabi-speaking participants, an 
alternative strategy was developed by the Steering group.  Two University of Birmingham 
medical students, with work placements in the Punjab region of India, agreed to collect these 
pilot data in India. The limitations of collecting comparative data in India rather than the UK 
were recognised and are discussed below. However, the study research team agreed that data 
from the Punjab may guide the development of future studies addressing illness perceptions of 
South Asians in the UK.  Patients were recruited from two hospitals in the city of Jalandhar, 
Punjab: Orthonova Joint and Trauma Hospital and Civil Hospital. Inclusion criteria were as for 
the UK sample except that to facilitate recruitment, those with concurrent depression, diabetes, 
cancer or chronic obstructive pulmonary disease were included, and the lower age limit was 60 
years for men as well as women.  
 
Pilot study participants in India completed translated versions of the Brief Illness Perception 
Questionnaire (BIPQ) (Broadbent et al., 2006), Oxford Hip Score (OHS), the Hospital Anxiety 
and Depression Scale (HADS), and patient basic socio-demographic information. Where 
validated translated versions were not available, such as for the BIPQ, questionnaires were 
translated into Punjabi, and independently back-translated. Discrepancies were then discussed, 





All of our findings were published in peer reviewed journals (Duggal et al., 2014a, Duggal et al., 
2015a, Duggal et al., 2014b, Duggal et al., 2013a, Duggal et al., 2015b, Phillips et al., 2015, 
Phillips et al., 2013). In summary, 101 hip fracture patients and 43 controls were recruited for the 
six week study. By six months, 66 hip fracture patients remained in the study. Withdrawals were 
due to death, being too unwell to be tested, being non-contactable or no longer meeting the 
inclusion criteria (e.g., taking anti-depressant medication).  The flow of participants through the 
study is shown in Figure 1. 
 





Hip fracture patients assessed for 
eligibility 
(n= 2260 ) 
Consented (n=200) 
Participated  at  
W6 (n=103 ) 
Non-depressed (n=65 ) 
Participated at  M6 (n=46) 
 
Analysed (n= 44) 
*Excluding 2 participants who did 
not meet inclusion criteria 
Withdrew prior to M6 (n= 21) 
*Unwell/died (n=9) 
*Other reason (n= 12) 
Depressed (n=38 ) 
Participated at M6 (n=24) 
 
Analysed (n=24) 
Withdrew prior to M6 (n= 14) 
*Unwell/died (n=8) 
* Other reason (n=6) 
Withdrawal prior  to W6 (n=97 ) 
* Unwell (n=38 ) 
*Other (n=59 ) 
Excluded (n=2060 ) 
* Not meeting inclusion criteria 
(n=1541 ) 
*Declined to participate (n=249 ) 
* Other reasons (n= 270) 
 
Participated at W6 
Healthy (n=43) 
 
Healthy Birmingham 1000 




Figure 1: Flow of participants through the study (modified from (Phillips et al., 2013) 
 
3.1 Participant characteristics  
 
Patients were classified into two groups on the basis of their depression scores: 37% of the hip 
fracture patients had depressive symptoms six weeks after their fracture. These groups differed 
on age and Body Mass Index (BMI), such that the non-depressed group was slightly younger and 
had a higher BMI.  However, there were no significant differences between the two hip fracture 
groups on other variables. At month 6, data were available for 66 hip fracture patients; 29% of 
whom were depressed. Participants classified as depressed had significantly higher GDS scores 
by an average of 5.6, at week 6. At month 6, this difference remained significant. 
 
3.2 Length of hospital stay and infections 
 
A range of hospital-related and community-acquired infection data were collected from patients’ 
hospital and GP notes within the six months post-hip fracture. The depressed group spent a 
significantly longer entire length of stay in hospitals or rehabilitation centres, although the length 
of inpatient stay at the hospital their surgery took place at did not significantly differ (Phillips et 
al., 2015). Hip fracture patients were significantly more likely to be discharged to a rehabilitation 
unit, and there was a slightly increased number of readmissions to hospital (Phillips et al., 2015).  
However, depressed patients did not have a greater number of infections while in hospital. 
Although they had a slightly higher number of infections in the six months following their hip 
fracture, this was not statistically significant (Phillips et al., 2015).  The types of infections 
experienced by depressed and non-depressed patients were not significantly different between 
groups. 
 












(HF + D) 
N = 38 
Healthy 
Controls 
N = 43 
 
Week 6  Number / Average 
Age (years) 83.8 84.0 74.9  
Sex (Female) 58 25 26  
Body Mass Index (kg/m2) 23.5 22.7 27.2  
Alcohol consumption (one or more units per week) 13 24 13  
Sleep (< 8hr per night)                     19 28 23  
 
3.3 Physical performance in hip fracture patients  
Physical frailty was assessed using four measures as described above. Patients with symptoms of 
depression were less able to engage in activities of daily living (ADL) than non-depressed 
patients at week six and month six although ADL significantly improved over time. Participants 
with depression took significantly longer to complete the Timed Up and Go (TUG) walking 
speed test at week six and month six, compared to the non-depressed group (Phillips et al., 2013). 
Both groups were far slower than age-related norms at both time-points, although walking speed 
improved over time in both groups. Depressed patients also scored significantly worse on the 
Berg Balance scale at week six compared to the non-depressed patients, but there was no 
significant difference by month six (Phillips et al., 2015).     
 
3.4 Neutrophil functioning in hip fracture patients  
  
When we compared neutrophil numbers between our hip fractured participants with and without 
depression and the healthy control group, significantly lower numbers were observed in healthy 
older adults compared with both groups of older adults with hip fracture, though all were within 
the normal range. Neutrophil phagocytosis (eating ability) did not differ significantly between the 
two groups of hip fracture patients and healthy controls. Neutrophil superoxide production 
(killing ability) in response to stimulation differed between our three groups, but the significant 
impairment was restricted to the hip fractured participants who developed depressive symptoms. 
Hip fracture patients with higher GDS scores had poorer neutrophil superoxide production 
(Duggal et al., 2013a).  
      
3.5 Monocyte  functioning in hip fracture patients  
Similar to neutrophils, monocytes play a key role in removal of pathogens and providing 
protection against infections.  We compared monocyte count between our three groups, but no 
significant differences were detected nor for monocyte phagocytic (eating) ability. Monocyte 
superoxide production (killing ability) was different between the three groups, but the significant 
impairment was restricted to the hip fracture patients who developed depression (Duggal et al., 
2014a), similar to our neutrophil data. Further, higher depression scores related to lower 
monocyte superoxide production (Duggal et al., 2014a), again in the same way as depression 
scores related to neutrophil function.  
 
3.6 NK cell numbers and cytotoxicity in hip fracture patients  
 
On examining NK cells in the participants, similar to the results above, we did not find any 
significant differences in percentages, or absolute numbers of NK cells between our three 
groups. However, a significant impairment in NK cell killing capacity was restricted to the hip 
fractured participants with new onset depression compared to healthy controls and those 
without depressive symptoms (Duggal et al., 2015a). Again, depressive symptoms predicted a 
reduction in NK cell killing ability, such that hip fracture patients with greater depressive 
symptoms had poorer NK cell activity.  
 
3.7 Hormone imbalance in hip fracture patients with depressive symptoms  
 
Analysis of stress hormone levels from the blood samples revealed significant differences: higher 
cortisol levels, reduced DHEAS levels, and an elevated serum cortisol:DHEAS ratio was 
observed in hip fracture patients with depressive symptoms compared to those with hip fracture 
alone and controls (Phillips et al., 2013).  Elevated serum cortisol:DHEAS ratios have been 
previously reported as an indicator of individuals at risk of depression (Young et al., 2002). Here, 
the higher the depression scores, the higher the cortisol:DHEAS ratio. However, the hormone 
ratio was not related to neutrophil, monocyte or NK cell function suggesting that it is not the 
main underlying link between depressive symptoms and impaired immune function.  
Interestingly, the ratio between these hormones did relate to physical function.  The 
cortisol:DHEAS ratio was related to walking speed as measured by the TUG at month six, such 
that the higher the cortisol:DHEAS ratio, the longer it took the participant to walk three metres 
(Phillips et al., 2013). This suggests that although this hormone ratio was not the link between 
depression and the immune changes we observed in participants with hip fracture, it may have a 
role to play in the markers of frailty we measured, at least in walking speed. 
 
3.8 Circulating cytokine levels in hip fracture patients with depressive symptoms 
Next, on measuring serum cytokine (immune messenger) levels in participants, we observed that 
hip fracture patients with depressive symptoms also had higher levels of pro-inflammatory 
cytokines, which are associated with higher levels of inflammation in the body, including IL6 and 
TNFα. We also observed higher levels of anti-inflammatory cytokines, such as IL10, in the 
participants with depression compared with non-depressed participants and controls, but overall 
depression scores did not positively relate to these levels (Duggal et al., 2013a). It is therefore 
unlikely that these immune messengers were the underlying link between depressive symptoms 
and immune function changes in our subjects.   
 
3.9 Reduced T cell numbers in hip fracture patients with depressive symptoms 
 
Finally, in an attempt to examine the effect of physical and psychological distress on adaptive 
immune cells (immune memory), we found several differences in cell numbers.  T-cell (so called 
as they mature in the thymus gland) numbers were significantly lower in our group of hip fracture 
patients with depressive symptoms compared with those without depression or healthy controls 
(Duggal et al., 2014b). T cells are composed of two main subsets, CD4 T cells (helper T cells that 
help other cells recognise pathogens) and CD8 T cells (cytotoxic T cells that kill infected cells 
directly). However, on examining the percentage of CD4+ve T cells and CD8+ve T cells no 
significant differences were observed between our three groups, or the ratio of these types of 
cells, which is sometimes higher in older or particularly stressed groups.   
 
3.10 Numerical and functional deficit in regulatory B cells  in hip fracture patients with 
depressive symptoms 
 
B cells, are a type of cell involved in recognising pathogens in the body and producing antibodies 
against them.  There are also specific types that help to regulate the function of the immune 
system to prevent over activity which might result in autoimmune disease.  In this study, there 
were no differences in the total numbers of B cells between the three groups. However, a 
significant decline was seen in percentage and absolute numbers of regulatory B cells in hip 
fracture patients with depressive symptoms compared with healthy controls and hip fracture 
patients without depressive symptoms (Duggal et al., 2015b). Further, participants with higher 
depressive symptoms (GDS score) had lower frequency of regulatory B cells (Duggal et al., 
2015b).  All of these immune, hormonal and physical function differences between the depressed 
and non-depressed participants at week 6 are summarised in Table 2. 
 
  
Table 2: Main group differences  
 Direction of Group Difference 
Geriatric Depression Scale Score* Depressed  > Not Depressed 
Neutrophil phagocytosis Depressed  = Not Depressed 
Neutrophil superoxide generation* Depressed  < Not Depressed 
Monocyte phagocytosis Depressed  = Not Depressed 
Monocyte superoxide generation* Depressed  < Not Depressed 
NK cell %/numbers Depressed  = Not Depressed 
NK cell killing* Depressed  < Not Depressed 
Cortisol* Depressed  > Not Depressed 
DHEA* Depressed  < Not Depressed 
Cortisol:DHEAS ratio* Depressed  > Not Depressed 
Pro-inflammatory cytokines* Depressed  > Not Depressed 
T-cell %/numbers* Depressed  < Not Depressed 
CD4/CD8 T cell numbers/ratio Depressed  = Not Depressed 
Regulatory B cell %* Depressed  < Not Depressed 
Regulatory B cell cytokine production* Depressed  < Not Depressed 
Oxford Hip Score* Depressed  < Not Depressed 
Hand Grip Mean (kg) Depressed  = Not Depressed 
Timed-Up-and-Go (seconds)*  Depressed  > Not Depressed 
Berg Balance Scale Score* Depressed  < Not Depressed 
Length of hospital/rehab centre stay* Depressed  > Not Depressed 





3.11 Long-term effect of depressive symptoms on hip fracture patients. 
 
Finally, the long term effect of depressive symptoms on hip fracture patients was evaluated six 
months post-surgery. We observed that during the six month follow-up, neutrophil superoxide 
production had improved in both hip fracture groups, but monocyte and NK cell functioning in 
hip fracture patients with depressive symptoms still remained suppressed six months post-
surgery. Further, the serum cortisol:DHEAS ratio remained high in the depressed group of hip 
fracture patients six months post hip surgery. This was not influenced by any change in reported 
depressive symptom scores at six weeks and six months, in fact there was very little change over 
time between the groups; six individuals who were not originally classified as depressed, were 
depressed at month six, and eleven who were initially depressed had recovered by month six. 
However, the biggest groups by far were those who had been depressed and remained so, and 
those who were not depressed and remained so.   
 
3.12 Pilot study results 
Next, our Punjabi sample was compared to our UK-based group of hip fracture patients on basic 
characteristics.  The Punjabi sample was somewhat younger than the Caucasian sample, and 
there were more males.  However, levels of anxiety and depression and activities of daily living 
scores were comparable across the samples. From the BIPQ, the Indian Punjabi group reported 
that they were significantly more affected by their hip fracture, perceived that the treatment had 
helped their hip fracture far less, and reported significantly more emotional distress resulting 
from their hip fracture compared to the UK sample. These differences are shown in Table 3 and 
were not driven by age and sex differences between the samples. Further, the Indian Punjabi 
group also reported higher levels of understanding about their hip fracture, but this became non-
significant when taking age and sex differences into account in statistical analyses.   
 
  
Table 3: Demographic and questionnaire pilot data in both samples 
 
 Mean (Standard 
Deviation) or Number (%) 
 UK India 
Age 84 (7.96) 71 (9.76) 
Sex (Male) 20 (20%) 11 (50%) 
Activities of Daily Living 27.5 (9.24) 22.5 (9.57) 
HADS Depression Score  ≥ 8 26 (27%) 8 (36%) 
HADS Anxiety Score     ≥ 8 29 (30%) 5 (23%) 
How much does your hip fracture affect your life? 6.0 (2.63) 7.45 (3.16) 
How long do you think your hip fracture will continue? 4.9 (2.63) 4.1 (3.29) 
How much control do you feel you have over the recovery from 
your hip fracture? 
5.5 (2.9) 6.4 (3.4) 
How much do you think your treatment helped your hip fracture? 7.4 (2.7) 1.6 (2.11) 
How much do you experience symptoms from your hip fracture? 4.3 (2.65) 3.7 (3.62) 
How concerned are you about your hip fracture? 4.6 (3.07) 5.8 (4.24) 
How well do you feel you understand your hip fracture? 5.4 (3.5) 7.4 (3.5) 
How much does your hip fracture affect you emotionally? 3.9 (3.16) 6.8 (4.08) 
Scores ranges from 10 = high or best to 0 = low or worst. 
 
All of the participants in both groups had fallen, but the reasons for the fall were perceived 
differently between the ethnic groups. The main cause provided by the UK Caucasian 
participants was that the hip fracture was due to the way that they fell (22%). This cause was not 
perceived by any of the Indian Punjabi participants, who attributed the main cause to be ‘fate’ 
(41%). However, difficulties in answering this open-ended question about the reason for the hip 
fracture in the Punjabi sample meant that this question was followed up with an additional probe: 
“Some people think that their fracture was due to fate or bad diet, do you think any of these 
factors caused your illness?” This is likely to have introduced some bias into the distribution of 
answers across the samples. Other perceived causes of hip fracture are shown in Table 4. 
 
  
Table 4: Participants’ perceptions of causes of hip fracture 
 
Perceived cause of hip fracture Number (%) 
 UK India 
The way they fell and landed 22 (22) 0 (0) 
Bone related cause (osteoarthritis or low calcium levels) 9 (9) 1 (4.5) 
Blamed themselves (e.g. for being careless) 7 (7) 0 (0) 
Dizziness 4 (4) 1 (4.5) 
Age 4 (4) 2 (9) 
Fate 0 (0) 9 (41) 




4.0 Implications in terms of policy and practice 
 
The clear implications arising from this research is that depression in older adults post-hip 
fracture is not only common, but can have a range of catastrophic consequences including poorer 
immunity across a whole range of immune measures, worse physical frailty and recovery, and 
longer stays in NHS facilities. Our findings support the need for preventing and treating 
depression and depressive symptoms to improve outcomes in older people with hip fracture, and 
that this should become common practice. One particular difficulty that this immediately raises is 
that patients with hip fracture are not routinely screened for depression symptoms, thus we would 
recommend this should be integrated into normal clinical practice. The use of a short scale such 
as the Geriatric Depression Scale would not add significant workload but would identify those 
patients at risk of poorer outcomes.  Interestingly, as well as group differences, our findings also 
showed that all immune outcomes were worse among those with the highest depression scores, 
meaning that for some individuals, the effects of untreated depressive symptoms post-fracture are 
very severe.  Poorer immune outcomes means that these patients are more at risk of infection 
(Butcher et al., 2005), which often results in mortality or at least return to hospital. Poor physical 
function outcomes means that these patients lose independence and are more likely to need to be 
admitted to rehabilitation facilities, or may not ever be fit enough to return home. Consequently, 
it is of great importance to identify such patients in terms or improving their health and wellbeing 
as well as reducing NHS costs in the longer term. Use of such a measurement would also indicate 
those patients struggling most emotionally after the physical trauma of their fracture, and thus 
identify those most in need of supportive care for up to six months post-fracture.  
 
There are also a number of obvious routes for intervention in these patients. Although 
participants’ GPs were informed of their involvement in the study and high depressive symptoms 
scores, this resulted in only two participants being prescribed anti-depressive medication. This 
may reflect that patients’ hip fracture is the main cause for concern and focus of treatment at this 
time, or also that common anti-depressant medications are contra-indicated in frail older adults 
due to interactions with osteoporosis and the risk of further serious injury. However, the 
difficulties inherent in not assessing and treating such symptoms are outlined above, thus it is 
likely that some type of psychological or pharmaceutical depression treatment would be helpful 
for these patients not only in terms of psychological wellbeing but also in terms of physical 
health and day to day functioning.  
 
The link with the cortisol:DHEAS ratio in the present study also suggests another route for 
intervention. As a higher ratio was related to poor physical frailty and slower walking speed 
recovery, it is possible that an intervention to adjust this ratio would have beneficial effects on 
recovery. DHEA tablets given as a nutritional supplement have been shown previously to be 
effective at increasing wellbeing and mood in older adults (Arlt et al., 2000, Arlt et al., 1999), 
improving some measures of physical function (Buvat, 2003), as well as being safe and well 
tolerated at doses of 50mg (Arlt et al., 1998).  Further,  DHEA supplementation is also known to 
modify immune function (Arlt and Hewison, 2004), for instance an immune enhancing effect of 
DHEAS has been reported on neutrophil superoxide generation (Radford et al., 2010) and  NK 
cell cytotoxicity (Solerte et al., 1999, Casson et al., 1993).  Although some studies have shown 
limited effectiveness in healthy populations, we believe the real effects of DHEA 
supplementation are likely to be seen among those with adrenal insufficiency or at acute risk of a 
high cortisol:DHEAS ratio, such as in our elderly depressed hip fracture patients. DHEA is also a 
cheap nutritional supplement, thus would not cost as much as testing as introducing a new anti-
depressant that is safe among older adults, or time-intensive psychological therapies. It is also 
possible that such treatment could be combined with some type of psychological support such as 
social support or talking therapy for older adults with depressive symptoms, which might result 
in even more positive health and wellbeing outcomes. Further research on the likely effectiveness 
as well as cost-effectiveness of such interventions is our next plan.  
 
The implications of our pilot research are limited by the inability to identify and recruit sufficient 
UK-based Punjabi patients. This reflects both low numbers of this group having hip fracture as 
well as difficulty with recruitment, even with a Punjabi speaking research assistant. Given this, 
our data are based on Punjabi patients in India where time since hip fracture and age of patients 
differed to our UK sample, making it difficult to generalise this group to a Punjabi patient group 
in the UK. However, it was interesting to note that Punjabi patients felt more affected and less 
effectively treated than UK Caucasian patients, and it would be interesting to conduct further 
research to see whether this might be the case also within the UK National Health Service or is 
specific to India.  Further, Punjabi patients were more likely to attribute their hip fracture to fate, 
whereas UK Caucasian patients attributed it to the way they fell.  However, caution should be 
taken here, as the questionnaires were conducted as interviews in the Punjab, and when answers 
were not forthcoming, the research assistants gave prompts based on previous patients’ answers, 
which are likely to have biased self-reports.  However, if further research were to replicate this 
finding without prompting from the researchers, it would raise interesting questions regarding 
patients’ understanding of illness and reasons for illness within the health care system in India, 
suggesting that more communication and education about the source of illness and reasons for 
treatment might be necessary.  This would be important as illness perceptions can affect patient 
engagement with the healthcare system and rehabilitation, with consequent effects on patient 
health and wellbeing outcomes. 
 
5.0 Conclusion summarising the key points, highlighting significance for ageing research, policy 
and practice, and indicating the next steps for research.  
 
In conclusion, this NDA project reported for the first time that development of depressive 
symptoms in older people who have suffered hip fracture can result in suppressive effect of 
psychological distress of depressive symptoms on neutrophil, monocytes and NK cell 
functioning in older hip fracture patients. Additionally, certain aspects of immunity in the 
participants with hip fracture and new onset depression remained suppressed even six months 
post-surgery. Further, the development of depressive symptoms post hip fracture induces HPA 
axis activation, resulting in elevated cortisol levels in people with hip fracture patients and 
depressive symptoms. Additionally, a reduction in serum DHEAS levels were also observed in 
these participants, resulting in an overall elevated serum cortisol: DHEAS ratio in hip fracture 
patients with new onset depression that remained elevated even six months post-surgery. We 
have also reported a reduced frequency of circulating B regulatory cells in hip fracture patients 
with depressive symptoms. These findings suggest that development of depressive symptoms 
after a hip fracture in older adults is the main driver of immune suppression, as we failed to find 
an immune decline as a result of hip fracture alone. Further, depression emerging post-hip 
fracture in older adults impaired physical function, including walking speed, balance, and 
activities of daily living. This showed for the first time that depressive symptoms in the absence 
of longer term pre-fracture depression diagnosis relate to recovery and physical frailty. Effects 
on walking speed were mediated by alterations in the cortisol:DHEAS ratio which was 
heightened among the depressed group.  Finally, the adults with hip fracture who developed 
depression were also more likely to spend longer in NHS facilities overall, incurring significant 
cost to the health service as well as inconvenience to patients not well enough to return home. 
 
This novel finding implies that in order to speed recovery of physical function, immunity and 
infection protection, and independence following hip fracture, patients should be assessed and 
treated for depressive symptoms. This is of relevance to surgeons and health professionals alike 
involved in rehabilitation post-fracture surgery who currently do not screen this patient group for 
depressive symptoms. Identification and treatment of depression in these patients would improve 
patient outcomes and quality of life as well as impacting upon health service costs incurred 
through treatment of those with slower recovery and decreased independence post-fracture. We 
propose that correcting the cortisol:DHEAS imbalance by oral supplementation with DHEA may 
be one means of improving depressed mood and contributing to better physical function after hip 
fracture. However, such an intervention would need to be cautiously informed by the intervention 
literature in order to determine an effect dosage and regime for an effect in these patients. It is 
possible that some form of psychological support on top of DHEA treatment might result in the 
best outcomes for patients who have developed depressive symptoms.  Consequently, the next 
stage in our research will be to pilot a randomized controlled trial of DHEA supplementation 
with and without psychological support in older adults with hip fracture and depression and 
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